Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2003
12/24/2003CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate
12/24/2003CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
12/24/2003CA2489870A1 Low molecular weight oversulfated polysaccharide
12/24/2003CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
12/24/2003CA2489648A1 Chemical process
12/24/2003CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003CA2489463A1 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
12/24/2003CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
12/24/2003CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003CA2489367A1 Compounds, compositions, and methods
12/24/2003CA2489312A1 Modulation of activation of glucocorticoid receptors .beta.-breakdown products of glucocorticoids
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament
12/24/2003CA2489179A1 Method of treating ischemia reperfusion injury using adenosine receptor antagonists
12/24/2003CA2489098A1 Bazedoxifene treatment regimens
12/24/2003CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
12/24/2003CA2488802A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003CA2488643A1 Coated particles, methods of making and using
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2488423A1 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
12/24/2003CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003CA2488111A1 Beverages containing plant sterols
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003CA2487122A1 Guanidine compounds as anesthetics and for treatment of nervous system disorders
12/24/2003CA2486557A1 Calcium salts of indole derived statins
12/24/2003CA2486215A1 Mitotic kinesin inhibitors
12/24/2003CA2485751A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions
12/24/2003CA2485346A1 Human adam-10 inhibitors
12/24/2003CA2479309A1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667319 Neuropeptide Y Y5 receptor antagonists
12/23/2003US6667317 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
12/23/2003US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates)
12/23/2003US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/23/2003CA2116387C Oxazolidinedione derivatives, their production and use
12/18/2003WO2003104818A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003WO2003104480A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor
12/18/2003WO2003104473A2 Galactosyl isomalt, method for production and use thereof
12/18/2003WO2003104260A2 Pharmaceutical formulation
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003104254A2 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003104228A1 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
12/18/2003WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104221A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003WO2003104219A1 Nf-kb inhibitors
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104216A1 Urotensin ii receptor modulators
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104200A1 N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
12/18/2003WO2003104197A1 Polymorphic form xvi of fexofenadine hydrochloride
12/18/2003WO2003104196A1 Non-peptidic brs-3 agonists
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003103771A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
12/18/2003WO2003103743A2 Medical device for intra-lumenal delivery of pharmaceutical agents
12/18/2003WO2003103721A1 Gene therapeutic for cerebrovascular disorders
12/18/2003WO2003103705A1 Metalloproteinase inhibitors
12/18/2003WO2003103698A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/18/2003WO2003103695A1 Novel therapeutic use of polypodium extracts
12/18/2003WO2003103693A1 Use of a preparation produced from plant seedlings, enriched with electrolyte
12/18/2003WO2003103687A1 Liquid formulation of decitabine and use of the same
12/18/2003WO2003103683A1 Use of estetrol and analogues for treating or preventing cardiovascular pathologies, in particular atherosclerosis
12/18/2003WO2003103675A2 Combination treatments for purinoceptor-related disorders
12/18/2003WO2003103671A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2003WO2003103651A1 Compounds of the formu;a r1-x-y-z-nr2r3 as abca-1 elevating agents against cad or atherosclerosis
12/18/2003WO2003103645A1 Fractionated extraction of natural source carotenoids with a high lycopene content, using supercritical fluids
12/18/2003WO2003103640A1 Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
12/18/2003WO2003103633A1 Nanoparticulate sterol formulations and sterol combinations
12/18/2003WO2003103632A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations
12/18/2003WO2003103631A1 Novel high viscosity embolizing compositions comprising prepolymers
12/18/2003WO2003103611A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
12/18/2003WO2003103608A2 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103603A2 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103585A2 Methods of treating angiogenesis, tumor growth, and metastasis
12/18/2003WO2003103583A2 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
12/18/2003WO2003103577A2 Novel recombinant anticoagulant proteins
12/18/2003WO2003103575A2 Compounds, compositions, and methods
12/18/2003WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
12/18/2003WO2003103475A2 Prevention and reduction of blood loss
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 1595